MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$99,525K
(21.86%↑ Y/Y)
Net loss
-$99,498K
(21.76%↑ Y/Y)
Unrealized (loss) on
marketable securities, net...
-$27K
(85.64%↑ Y/Y)
Other income, net
$5,068K
(-59.59%↓ Y/Y)
Loss from operations
-$104,566K
(25.16%↑ Y/Y)
Revenue
$12,140K
(73.43%↑ Y/Y)
Total operating
expenses
$116,706K
(-20.45%↓ Y/Y)
Research and development
$94,300K
(-20.08%↓ Y/Y)
General and
administrative
$22,406K
(-21.98%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)